The suppressive effects of YM155 on NF-κB signaling provide a wider perspective on the pharmacodynamic effects elicited by this unusual molecule and potentially, its use in therapeutic combinations to enhance the clinical efficacy in the treatment of RCC and other cancers. Here, NFKB1 is linked to cancer.